Christina (Tina) P./LinkedIn
Jun 21, 2026, 14:38
Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Bleeding Risks and Blood Thinners: APS Awareness Day 21
Blood thinners (also called anticoagulants) are medicines that prevent blood clots.
They’re often used in conditions like Antiphospholipid Syndrome (APS) to reduce the risk of strokes, deep vein thrombosis (DVT), and other clot-related issues.
Blood thinners save lives by preventing dangerous clots — but they must be taken carefully to avoid serious bleeding.
Knowing the risks helps you stay safe and prepared.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?